<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cell substitution in the form of "tailored haemotherapy " should be an essential part of medical <z:hpo ids='HP_0002664'>oncology</z:hpo> at the present time </plain></SENT>
<SENT sid="1" pm="."><plain>In the conventional therapy of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> patients do not enter into prolonged phases of severe haemopoietic insufficiency </plain></SENT>
<SENT sid="2" pm="."><plain>Accordingly platelet and granulocyte transfusions will be exceptional </plain></SENT>
<SENT sid="3" pm="."><plain>It is mainly the red cell transfusion which plays the most important role </plain></SENT>
<SENT sid="4" pm="."><plain>The possible complication of cell substitution should always be kept in mind </plain></SENT>
<SENT sid="5" pm="."><plain>Here the risk of <z:e sem="disease" ids="C0948201" disease_type="Disease or Syndrome" abbrv="">alloimmunisation</z:e> which makes a continuation of transfusion therapy or a subsequent bone marrow transplantation problematic, is just one of the examples </plain></SENT>
<SENT sid="6" pm="."><plain>Modern cell separation techniques allow the production of highly concentrated cell preparations aiming at the reduction of the frequency of transfusions and minimizing the risk of sensitisation </plain></SENT>
<SENT sid="7" pm="."><plain>If rich concentrated preparations have to be given to immunodeficient patients an irradiation should proceed their transfusion, otherwise the immunocompetent lymphocytes contained in the preparations could induce graft versus host reactions </plain></SENT>
<SENT sid="8" pm="."><plain>Allogenic bone marrow transplantation is more becoming the treatment of choice for <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo>, severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>At the present time the place of allogeneic or autologous bone marrow transplantation as a treatment of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> is still unsettled </plain></SENT>
</text></document>